RPE65-associated Leber congenital amaurosis
Showing 1 - 25 of >10,000
Leber Congenital Amaurosis Associated With Mutations in RPE65
Recruiting
- Leber Congenital Amaurosis
-
Ann Arbor, Michigan
- +1 more
Apr 7, 2022
Inherited Retinal Dystrophy Due to RPE65 Mutations, Leber Congenital Amaurosis Trial in Iowa City, Philadelphia
Active, not recruiting
- Inherited Retinal Dystrophy Due to RPE65 Mutations
- Leber Congenital Amaurosis
- AAV2-hRPE65v2,voretigene neparvovec-rzyl
-
Iowa City, Iowa
- +1 more
Dec 9, 2021
Amaurosis of Leber, Retinal Diseases Trial in Gainesville, Philadelphia (rAAV2-CBSB-hRPE65)
Active, not recruiting
- Amaurosis of Leber
- Retinal Diseases
- rAAV2-CBSB-hRPE65
-
Gainesville, Florida
- +1 more
Dec 13, 2021
To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)
Not yet recruiting
- To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)
- (no location specified)
Aug 29, 2023
Leber Congenital Amaurosis Trial in Shanghai (HG004)
Recruiting
- Leber Congenital Amaurosis
- HG004
-
Shanghai, Shanghai, ChinaXinhua Hospital affiliated with Shanghai Jiao Tong UniversitySch
Oct 12, 2023
Leber Congenital Amaurosis Trial in Shanghai (HG004)
Recruiting
- Leber Congenital Amaurosis
- HG004
-
Shanghai, Shanghai, ChinaXinhua Hospital affiliated with Shanghai Jiao Tong University Sc
Sep 26, 2023
Leber Congenital Amaurosis Trial in Philadelphia (voretigene neparvovec-rzyl)
Completed
- Leber Congenital Amaurosis
- voretigene neparvovec-rzyl
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Oct 30, 2020
Choroideremia Trial in Edmonton (rAAV2.REP1 vector)
Completed
- Choroideremia
- rAAV2.REP1 vector
-
Edmonton, Alberta, CanadaUniversity of Alberta
May 16, 2022
Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy Trial in United States (AAV2-hRPE65v2,voretigene
Active, not recruiting
- Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy
- AAV2-hRPE65v2,voretigene neparvovec-rzyl
-
Los Angeles, California
- +9 more
Oct 22, 2021
Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)
Active, not recruiting
- Inherited Retinal Dystrophy Due to RPE65 Mutations
- AAV2-hRPE65v2
- (no location specified)
Dec 9, 2021
Leber Congenital Amaurosis Trial in Jerusalem (rAAV2-hRPE65)
Completed
- Leber Congenital Amaurosis
- rAAV2-hRPE65
-
Jerusalem, IsraelHadassah Medical Organization
Apr 8, 2018
Leber Hereditary Optic Neuropathy Trial in Wuhan (rAAV2-ND4)
Active, not recruiting
- Leber Hereditary Optic Neuropathy
-
Wuhan, Hubei, ChinaDepartment of Ophthalmology,Tongji Hospital, Tongji Medical Coll
Sep 15, 2020
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Biallelic RPE65 Mutation-associated Retinal Dystrophy Trial in Beijing (FT-001 Low Dose, FT-001 Mid Dose, FT-001 High Dose)
Recruiting
- Biallelic RPE65 Mutation-associated Retinal Dystrophy
- FT-001 Low Dose
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 11, 2023
Leber Congenital Amaurosis Trial in Worcester, Portland (rAAV2-CB-hRPE65)
Completed
- Leber Congenital Amaurosis
- rAAV2-CB-hRPE65
-
Worcester, Massachusetts
- +1 more
Dec 1, 2017
Leber Congenital Amaurosis 10, Inherited Retinal Dystrophies, Eye Diseases, Hereditary Trial in United States (EDIT-101)
Active, not recruiting
- Leber Congenital Amaurosis 10
- +6 more
-
Miami, Florida
- +4 more
Dec 2, 2022
Acute LHON, Onset Within Three Months, Onset Between 3 to 6 Months Trial in Wuhan (rAAV2-ND4)
Unknown status
- Acute LHON
- +6 more
-
Wuhan, Hubei, ChinaDepartment of Ophthalmology ,Tongji Hospital, Tongji Medical Col
Jul 27, 2020
Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Worldwide (sepofarsen, Sham)
Active, not recruiting
- Leber Congenital Amaurosis 10
- +9 more
- sepofarsen
- Sham
-
Iowa City, Iowa
- +13 more
Mar 2, 2022
Cell Collection to Study Eye Diseases
Recruiting
- Retinal Disease
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Retinal Disorder Trial in New York (Placebos, ZA Low dose, ZA high dose)
Suspended
- Retinal Disorder
- Placebos
- +2 more
-
New York, New YorkNY NY
Oct 7, 2020
Leber Congenital Amaurosis, Retinitis Pigmentosa Trial in Beijing (Human primary Retinal Pigment Epithelial (HuRPE) cells)
Unknown status
- Leber Congenital Amaurosis, Retinitis Pigmentosa
- Human primary Retinal Pigment Epithelial (HuRPE) cells
-
Beijing, ChinaBeijing Tongren Hospital
Aug 7, 2018
Retinitis Pigmentosa Trial in Bangkoknoi (BM-MSC)
Completed
- Retinitis Pigmentosa
- BM-MSC
-
Bangkoknoi, Bangkok, ThailandSiriraj Hospital Mahidol University
Aug 31, 2021
Genetic Variants in Nicotinamide Adenine Dinucleotide Synthesis
Active, not recruiting
- Vacterl Association
- Congenital Malformation
-
Rochester, MinnesotaMayo Clinic
Jan 10, 2023